Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1991
03/05/1991US4997949 Crystalline 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl) thiazole dihydrochloride trihydrate
03/05/1991US4997943 Bactericides
03/05/1991US4997931 Epipodophyllotoxin glycosides
03/05/1991US4997926 Viricides
03/05/1991US4997924 5'-deoxy-4',5'-unsaturated-5'-substituted adenosines
03/05/1991US4997854 Enzyme inhibitors
03/05/1991US4997853 Method and compositions utilizing capsaicin as an external analgesic
03/05/1991US4997852 Mammary cancer
03/05/1991US4997851 Antiviral and antibacterial activity of fatty acids and monoglycerides
03/05/1991US4997850 Alcohol or ester
03/05/1991US4997847 Biologically active compounds
03/05/1991US4997846 Smooth muscle relaxants, hypotensives
03/05/1991US4997844 Compounds for the treatment of allergic or inflammatory diseases or shock conditions
03/05/1991US4997843 Platelet activating factor, anticoagulants
03/05/1991US4997841 Indole derivatives
03/05/1991US4997840 Quinolone sulphonates having antihypertensive activity
03/05/1991US4997839 2-quinolyl ethers
03/05/1991US4997835 Bactericides, malaria, antitumor
03/05/1991US4997833 Aryloxy-aminoalkanes, and antihypertensive use thereof
03/05/1991US4997831 Lactam derivatives
03/05/1991US4997830 Pharmaceutical composition for the treatment of periodontitis
03/05/1991US4997829 Antibiotics
03/05/1991US4997828 Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin
03/05/1991US4997827 Compositions containing 5-α-dihydro-19-norethisterone and derivatives thereof for in vivo inhibition of aromatase
03/05/1991US4997826 Tetrahydrocortisol in glaucoma therapy
03/05/1991US4997824 Bone disorders
03/05/1991US4997823 Anti-infective injectable formulations
03/05/1991US4997818 Using a nitrogenous heterocyclic base and dideoxy-pentose monosaccharides
03/05/1991US4997814 Corticosteroid binding globulin and antiinflammatory agent that binds to it
03/05/1991US4997761 Phosphatidyl treatment of viral disease
03/05/1991US4997658 Method for enhancing the lowering of plasma cholesterol levels
03/05/1991US4997657 Linolenic acid/g-/ and di-homo-gamma-linolenic acid
03/05/1991US4997654 Method for increasing salivation for xerostomia patients
03/05/1991US4997653 Method for treating endometriosis with topical preparations containing danazol
03/05/1991US4997651 Pharmaceutical formulations
03/05/1991US4997645 Administering interferon and dipyridamole
03/05/1991US4997644 Ethylene oxide-propylene oxide copolymer
03/05/1991US4997643 Polymeric salt delivery systems
03/05/1991US4997640 Oral compositions
03/05/1991CA2024485A1 Tetrasaccharides and process for their preparation
03/05/1991CA2024438A1 External preparation containing amusulosin
03/05/1991CA2024396A1 Compounds
03/05/1991CA2023099A1 Amino acid derivatives
03/05/1991CA1281150C Process for the preparation of curable fluoroelastomers and products so obtained
03/05/1991CA1281030C Dihydrobenzopyran derivatives
03/05/1991CA1281029C Optically active ketals, processes for their preparation and their use in the synthesis of ó-arylakanoic acids
03/05/1991CA1280987C Antibacterial composition
03/05/1991CA1280977C Polyprenyl alcohol-containing injections
03/05/1991CA1280976C Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thusobtained
03/05/1991CA1280974C Transdermal delivery system
03/03/1991CA2024167A1 Hyposensitization agent
03/02/1991WO1991003482A1 New bis-platinum complexes as chemotherapeutic agents
03/02/1991WO1991003260A1 Antisense oligonucleotides to c-abl proto-oncogene
03/02/1991CA2065294A1 Antisense oligonucleotides to c-abl proto-oncogene
03/02/1991CA2024489A1 Method of inhibiting virus
03/02/1991CA2024359A1 Anthelmintics
03/02/1991CA2024235A1 Epipodophyllotoxin altroside derivatives
03/02/1991CA2023995A1 Stable solutions of mitomycin c
03/02/1991CA2021548A1 Effervescent cold or sinus allergy medicine composition having reduced sodium content
03/01/1991WO1991003466A1 Substituted quinolines
03/01/1991WO1991003227A1 Topical antiinflammatory compositions with minimal systemic absorption
03/01/1991CA2065374A1 Method of dissolving cholesterol-rich calculi with short chain halogenated organic solvents and cosolvents
03/01/1991CA2064189A1 Topical antiinflammatory compositions with minimal systemic absorption
03/01/1991CA2064015A1 Substituted quinolines
03/01/1991CA2024300A1 Acat inhibitors
03/01/1991CA2024267A1 Beta-lactams as anticholesterolemic agents
03/01/1991CA2024252A1 Indolobenzoquinoline derivatives, their preparation and their use as anti-arrythmic drugs
03/01/1991CA2024248A1 7-substituted hmg-coa reductase inhibitors
03/01/1991CA2024137A1 Aza compounds
03/01/1991CA2024113A1 Substituted pyrimidinones as angiotensin ii antagonists
03/01/1991CA2024072A1 Pyrido [2,3-b] [1,4]benzoxazepin (and thiazepin) -6(5h)-ones and -thiones and their use in the prevention or treatment of aids
03/01/1991CA2024055A1 Dipyrido/3,2-b:2'3'-e//1,4/oxazepin (and thiazepin)-6(5h)-ones and-thiones and their use in the prevention or treatment of aids
03/01/1991CA2024011A1 1-substituted-1,2-dihydro-4-[(substituted)-phenyl]imidazo-[ 1,5-a]pyrimidine-8-carbonitriles
03/01/1991CA2023790A1 1,5-benzothiazepine derivatives and preparation thereof
03/01/1991CA2021408A1 Method for treating hypermotility diseases of the bowel employing an ace inhibitor and formulation for use therein
02/1991
02/28/1991DE3928287A1 Verwendung des (+)-enantiomeren von anipamil Use of (+) - enantiomer of anipamil
02/28/1991DE3927596A1 Use of xanthine derivs. to reduce nephrotoxicity
02/28/1991CA2009461A1 L-glutamic acid derivatives
02/27/1991WO1991002524A1 Use of the (+)-enantiomer of anipamil
02/27/1991EP0414607A2 Anti-sense nucleotide sequence, anti RNA against alpha TNF messenger RNA, process for the preparation thereof, medical use thereof and its inclusion in pharmaceutical preparations
02/27/1991EP0414606A2 Omega-phenyl amino alkanoic acids, substituted on the phenyl ring by a 19-nor steroid group, their salts, a process for their preparation and intermediates of this process, their use as medicines and pharmaceutical compositions thereof
02/27/1991EP0414605A1 Pasty aqueous pharmaceutical compositions
02/27/1991EP0414568A2 Use of anticholinergic compounds for protecting the central nervous system against cholinergic neurotoxins
02/27/1991EP0414530A2 3-Nitro-substituted steroid derivatives
02/27/1991EP0414529A2 7-Keto- and 7-Hydroxy-androsta-3,5-diene-3-carboxylic acid derivatives
02/27/1991EP0414493A2 2-(heterocyclylalkyl) phenyl carbapenem antibacterial agents
02/27/1991EP0414492A1 2-(heterocyclheterioaryliumalkyl) phenyl carbapenem antibacterial agents
02/27/1991EP0414491A2 17 Beta-acyl-4-aza-5 alpha-androst-1-ene-3-ones as 5 alpha-reductase inhibitors
02/27/1991EP0414490A2 17 Beta-acyl-4-aza-5 alpha-androst-1-ene-3-one as 5 alpha-reductase inhibitors
02/27/1991EP0414489A2 2-(Quinoliniumalkyl and isoquinoliniumalkyl) phenyl carbapenem antibacterial agents
02/27/1991EP0414422A2 2-Oxo-1-oxa-8-azaspiro [4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
02/27/1991EP0414421A2 1-Oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
02/27/1991EP0414394A2 Azabicyclic Derivatives having muscarinic receptor affinity
02/27/1991EP0414391A2 Aminoketone derivatives and use thereof
02/27/1991EP0414373A2 Stable solution of hyaluronate in a balanced salt medium
02/27/1991EP0414289A1 Spirocyclic antipsychotic agents
02/27/1991EP0414263A2 Process for the stabilisation of a solid pharmaceutical composition comprising cyclic amino acids.
02/27/1991EP0414216A2 Cyclic pyridin-2,4- and 2,5-dicarboxylic acid diamides, process for their preparation and their use
02/27/1991EP0414206A2 2,4,6-Substituted phenol derivatives
02/27/1991EP0414200A2 Salts of optically active 4-hydroxy-8-(3-lower alkoxy-4-phenylsulfinylphenyl)pyrazolo [1,5-a]-1,3,5-triazines and a process for production thereof
1 ... 7364 7365 7366 7367 7368 7369 7370 7371 7372 7373 7374 7375 7376 7377 7378 7379 7380 7381 7382 7383 7384 ... 7860